Interleukin-6 as an early marker for the diagnosis neonatal septicemia

Abstract

Sepsis is a leading cause of death and morbidity in newborns, especially those with very low birth weight and premature babies. The aim of our study diagnoses bacterial neonatal septicemia by direct techniques and some immunological biomarkers. The present study would include 75 neonates with clinically suspected neonatal sepsis and 50 healthy controls. Interleukin -6 levels of the blood were significantly higher in the suspected neonatal septicemia group compared with the control group. A significant increase in IL-6 levels in the blood can be used to make diagnose sepsis early.